Milena Bruzzone

1.6k total citations
45 papers, 1.1k citations indexed

About

Milena Bruzzone is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Milena Bruzzone has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Reproductive Medicine, 20 papers in Surgery and 12 papers in Obstetrics and Gynecology. Recurrent topics in Milena Bruzzone's work include Ovarian cancer diagnosis and treatment (30 papers), Intraperitoneal and Appendiceal Malignancies (13 papers) and Endometrial and Cervical Cancer Treatments (11 papers). Milena Bruzzone is often cited by papers focused on Ovarian cancer diagnosis and treatment (30 papers), Intraperitoneal and Appendiceal Malignancies (13 papers) and Endometrial and Cervical Cancer Treatments (11 papers). Milena Bruzzone collaborates with scholars based in Italy, United Kingdom and United States. Milena Bruzzone's co-authors include Pierfranco Conté, A. Rubagotti, Riccardo Rosso, Angiolo Gadducci, F Carnino, Elisabetta Campora, S. Chiara, Laura Merlini, S. Chiara and R. Rosso and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Milena Bruzzone

44 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milena Bruzzone Italy 18 607 434 336 315 138 45 1.1k
Masamichi Hiura Japan 16 705 1.2× 251 0.6× 198 0.6× 750 2.4× 79 0.6× 50 1.2k
Enrico Breda Italy 16 730 1.2× 370 0.9× 273 0.8× 363 1.2× 82 0.6× 39 996
Fernando O. Recio United States 19 416 0.7× 371 0.9× 181 0.5× 350 1.1× 84 0.6× 45 994
Hitoshi Hareyama Japan 20 605 1.0× 303 0.7× 257 0.8× 842 2.7× 75 0.5× 42 1.3k
Taymaa May Canada 17 662 1.1× 317 0.7× 259 0.8× 457 1.5× 61 0.4× 94 1.1k
M Mascarenhas United Kingdom 7 936 1.5× 604 1.4× 205 0.6× 471 1.5× 37 0.3× 9 1.3k
F Carnino Italy 17 398 0.7× 257 0.6× 439 1.3× 156 0.5× 128 0.9× 39 914
Frédéric Buxant Belgium 16 486 0.8× 142 0.3× 264 0.8× 326 1.0× 122 0.9× 49 1.1k
Larry E. Puls United States 14 588 1.0× 237 0.5× 130 0.4× 301 1.0× 91 0.7× 29 868
Jonathan Herod United Kingdom 7 1.0k 1.7× 623 1.4× 232 0.7× 576 1.8× 57 0.4× 8 1.2k

Countries citing papers authored by Milena Bruzzone

Since Specialization
Citations

This map shows the geographic impact of Milena Bruzzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milena Bruzzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milena Bruzzone more than expected).

Fields of papers citing papers by Milena Bruzzone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milena Bruzzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milena Bruzzone. The network helps show where Milena Bruzzone may publish in the future.

Co-authorship network of co-authors of Milena Bruzzone

This figure shows the co-authorship network connecting the top 25 collaborators of Milena Bruzzone. A scholar is included among the top collaborators of Milena Bruzzone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milena Bruzzone. Milena Bruzzone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carbotti, Grazia, Anna Maria Orengo, Delia Mezzanzanica, et al.. (2012). Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors. International Journal of Cancer. 132(11). 2597–2605. 41 indexed citations
2.
Bruzzone, Milena, Maria Grazia Centurioni, Marina Gualco, et al.. (2011). Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study. Oncology. 80(3-4). 238–246. 7 indexed citations
3.
Orengo, Anna Maria, Marina Fabbi, Loredana Miglietta, et al.. (2010). Interleukin (IL)‐18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursor. International Journal of Cancer. 129(5). 1116–1125. 19 indexed citations
4.
Miglietta, Loredana, P. Franzone, Maria Grazia Centurioni, et al.. (2006). A Phase II Trial with Cisplatin-Paclitaxel Cytotoxic Treatment and Concurrent External and Endocavitary Radiation Therapy in Locally Advanced or Recurrent Cervical Cancer. Oncology. 70(1). 19–24. 24 indexed citations
5.
Bruzzone, Milena, Loredana Miglietta, P. Franzone, Angiolo Gadducci, & Francesco Boccardo. (2004). Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III–IV endometrial cancer patients. Gynecologic Oncology. 93(2). 345–352. 46 indexed citations
6.
7.
Bruzzone, Milena, A. Rubagotti, Angiolo Gadducci, et al.. (1997). Intraperitoneal Carboplatin with or without Interferon-α in Advanced Ovarian Cancer Patients with Minimal Residual Disease at Second Look: A Prospective Randomized Trial of 111 Patients. Gynecologic Oncology. 65(3). 499–505. 24 indexed citations
8.
Conté, Pierfranco, Milena Bruzzone, F Carnino, et al.. (1996). High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.. Journal of Clinical Oncology. 14(2). 351–356. 69 indexed citations
9.
Bruzzone, Milena, Angiolo Gadducci, Serafina Mammoliti, et al.. (1995). Prognostic factors affecting long-term survival of advanced ovarian cancer (AOC) patients (pts): univariate and multivariate analysis at 12 years follow-up. 14. 286. 4 indexed citations
10.
Chiara, Silvana, Pierfranco Conté, P. Franzone, et al.. (1994). High-Risk Early-Stage Ovarian Cancer Randomized Clinical Trial Comparing Cisplatin Plus Cyclophosphamide versus Whole Abdominal Radiotherapy. American Journal of Clinical Oncology. 17(1). 72–76. 41 indexed citations
11.
Chiara, Silvana, Milena Bruzzone, Laura Merlini, et al.. (1994). Randomized Study Comparing Chemotherapy Plus Radiotherapy Versus Radiotherapy Alone in FIGO Stage IIB-III Cervical Carcinoma. American Journal of Clinical Oncology. 17(4). 294–297. 44 indexed citations
12.
Bruzzone, Milena, Elisabetta Campora, Silvana Chiara, et al.. (1993). Cerebral Metastases Secondary to Ovarian Cancer: Still an Unusual Event. Gynecologic Oncology. 49(1). 37–40. 48 indexed citations
13.
Repetto, Lazzaro, Serafina Mammoliti, Milena Bruzzone, et al.. (1993). The impact of received dose intensity on the outcome of advanced ovarian cancer. European Journal of Cancer. 29(2). 181–184. 29 indexed citations
14.
Chiara, S., Serafina Mammoliti, Cristina Oliva, et al.. (1991). Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experience. European Journal of Cancer and Clinical Oncology. 27(10). 1211–1215. 8 indexed citations
15.
Bruzzone, Milena, Elisabetta Campora, Laura Merlini, et al.. (1991). Ifosfamide and Etoposide Salvage Treatment in Advanced Ovarian Cancer. Journal of Chemotherapy. 3(5). 332–334. 4 indexed citations
16.
Bruzzone, Milena, Elisabetta Campora, S. Chiara, et al.. (1990). CA-125 monitoring in the management of ovarian cancer.. PubMed. 10(5A). 1353–9. 6 indexed citations
17.
Bruzzone, Milena, Lazzaro Repetto, S. Chiara, et al.. (1990). Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second look. Gynecologic Oncology. 38(3). 392–395. 44 indexed citations
18.
Bruzzone, Milena, Pierfranco Conté, Michael Ruvolo, et al.. (1989). Evaluation of the Ovarian Cancer Antigen, CA-125, as a Tumor Marker. Oncology. 46(2). 117–122. 7 indexed citations
19.
Conté, Pierfranco, Milena Bruzzone, S. Chiara, et al.. (1986). A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.. Journal of Clinical Oncology. 4(6). 965–971. 122 indexed citations
20.
Ferrini, Silvano, Roberto Biassoni, Alessandro Moretta, et al.. (1985). CLONAL ANALYSIS OF T LYMPHOCYTES ISOLATED FROM OVARIAN CARCINOMA ASCITIC FLUID. PHENOTYPIC AND FUNCTIONAL CHARACTERIZATION OF T‐CELL CLONES CAPABLE OF LYSING AUTOLOGOUS CARCINOMA CELLS. International Journal of Cancer. 36(3). 337–343. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masamichi Hiura Breakdown of academic impact, for papers by Enrico Breda Breakdown of academic impact, for papers by Fernando O. Recio Breakdown of academic impact, for papers by Hitoshi Hareyama Breakdown of academic impact, for papers by Taymaa May Breakdown of academic impact, for papers by M Mascarenhas Breakdown of academic impact, for papers by F Carnino Breakdown of academic impact, for papers by Frédéric Buxant Breakdown of academic impact, for papers by Larry E. Puls Breakdown of academic impact, for papers by Jonathan Herod
Rankless by CCL
2026